#1 Cause of Vision Loss in Adults? Diabetes.

Diabetic retinopathy is the #1 cause of vision loss among working adults between the ages of 20 and 74 in the United States.* Lucentis recently gained FDA approval for monthly treatment of every form of diabetic retinopathy. This marks the first drug that the FDA has approved to treat diabetic retinopathy “with or without diabetic macular […]

App allows users to ‘see’ retinal disease

A new virtual and augmented reality app called “In My Eyes” allows users to experience what it is like to have different kinds of retinal disease. Regeneron Pharmaceuticals teamed with Intouch Solutions to create the app. Available for free download in the iTunes and Google app stores, the app can be used with or without […]

Americans’ Greatest Health Fear? Going Blind

A study conducted by the Wilmer Eye Institute at Johns Hopkins University School of Medicine found that most Americans deem loss of vision as the worst thing that could happen to them even when compared to memory loss, loss of speech, hearing or loss of limb or having HIV/AIDS. Despite the fact that most Americans […]

Diabetics more likely to skip eye exams

Despite having a higher risk of developing serious eye diseases that could potentially rob them of their vision, nearly 60 percent of diabetics do not have yearly eye exams. Diabetics are at a greater risk of losing their vision to diabetic retinopathy and the disease can lead to additional blinding eye problems if not caught early and […]

Diabetes risk doubled with 2 sweet drinks daily

Regardless of whether you consume two or more 200 – milliliter servings of sugar sweetened drinks or artificially sweetened drinks on a daily basis, a recent study found that your risk of developing type 2 diabetes is almost doubled.  If your intake is more than 5 200 – milliliter servings a day then you have […]

Lucentis Prefilled Syringe approved by FDA

Doctors will now have an alternative when it comes to administering Lucentis injections for patients with advanced macular degeneration or diabetic retinopathy. The FDA recently announced its approval of .5 mg pre-filled syringes of Luncentis for the treatment of patients with wet age-related macular degeneration, macular edema and retinal vein occlusion. Currently, physicians have several […]

Testing blood sugar with a contact lens

For diabetics who must endure blood testing to check their glucose levels, a pain-free method may soon be available in the form of a contact lens. Researchers at the University of Houston published results of a study in the journal Advanced Materials. Armed with the knowledge that glucose is present in blood as well as […]

Google’s Artificial Intelligence may save eyesight

Optical Coherence Tomography (OCT) is what is currently used to diagnose diabetic retinopathy and age-related macular degeneration. The problem with this digital scanning method is that it is highly complex and time-consuming for eye care professionals to analyze. This adds up to time lost in diagnosing and treating as early as possible. Aware of this, […]

Eylea effective for Diabetic Retinopathy

A two-year clinical trial has found that diabetic patients suffering from severe vision loss from diabetic macular edema benefit the most from receiving treatment with Eylea versus Avastin or Lucentis. Eylea was just approved for use by the FDA for treating diabetic macular edema patients last year. The study was conducted by the National Institutes […]

Lucentis beats lasers in treating diabetic retinopathy

A study funded by the National Eye Institute determined that Lucentis injections trumped laser therapy in treating proliferative diabetic retinopathy. The study results were published in the Journal of the American Medical Association online. 305 patients were included in the study with half of them receiving monthly Lucentis injections for three months and then only […]